Pentasa Sachets 4 G 4 g Prolonged release granules
PDF Leaflet Revision Date: 17 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate ulcerative colitis and Crohnu2019s disease.
Dosage (summary)
Adults: Up to 4 g mesalazine daily; Maintenance: 2 g once daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use with caution; potential risks in pregnancy and breastfeeding.
Key Drug Interactions
- Azathioprine
- NSAIDs
- Warfarin
Contraindications
- Hypersensitivity to mesalazine
- Severe liver and/or renal impairment
Common side effects
- Diarrhoea
- Nausea
- Abdominal pain
- Headache
- Vomiting
- Rash
Counselling Points
- Do not chew granules
- Ensure adequate fluid intake
- Report any severe skin reactions
Serious warnings
- Severe cutaneous adverse reactions
- Monitor liver and renal function
Important Disclaimer
The Pentasa Sachets 4 G 4 g Prolonged release granules professional information leaflet below is the property of Ferring and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
